Atlas of Genetics and Cytogenetics in Oncology and Haematology


Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

MYST3 (MYST histone acetyltransferase (monocytic leukemia) 3

Identity

Other namesMOZ (monocytic leukemia zinc finger)
ZNF220
RUNXBP2
Hugo MYST3
Location 8p11

DNA/RNA

Description The gene spans121 kb on minus strand; 17 exons;
Transcription 7.85 kb

Protein

 
Description 2004 amino acids; 225 kDa; composed from N-term of: a NEMM domain (N-term region of ENOK, MOZ or MORF) including a H15 (linker H1 and H5 like) nuclear localization domain, 2 PHD (plant homeodomain, also known as LAP (leukemia associated protein)) Zn fingers (C4HC3), a C2HC Zn finger, essential part of the histone acyl transferase domain (HAT MOZ-SAS), an acidic (Glu-Asp) domain, localisation of breakpoints in the inv(8) and in the t(8;22) in 1118, and a Ser-(Pro-Glu)-Met rich domain, localisation of the t(8;16) breakpoint in 1547.
Localisation nucleus
Function lysine acetyltransferase activity (histone acyl transferase); MYST3 (MOZ) and MYST4 (MORF) possess both transcription activation and transcription repression domains; transcriptional regulators; interact with RUNX1 and RUNX2; Moz, the zebrafish ortholog of MYST3, was also found to regulate Hox expression; Moz behaves like a trithorax group factor
Homology with MYST4 (MORF) (monocytic leukemia zinc finger protein-related factor), a transcription regulator with positive and negative domains and activities

Implicated in

Entity t(2;8)(p23;p11) in therapy related myelodysplastic syndrome --> MYST3 / ?
Disease only 1 case to date, a boy aged 6 yrs
  
Entity inv(8)(p11q13) in acute myelomonocytic or monocytic leukaemia (M4 or M5 AML) --> MYST3 / NCOA2
Disease Erythrophagocytosis; very rare: less than 10 cases; young age, and female sex
Prognosis likely to be poor
Hybrid/Mutated Gene 5' MYST3 - 3' NCOA2
Abnormal Protein The fusion product retains the zinc fingers, the the histone acetyl transferase (HAT) domain of MYST3 and the HAT domains and CREBBP interacting domain of NCOA2
  
Entity t(8;16)(p11;p13) in acute myelomonocytic or monocytic leukaemia (M4 or M5 AML) and therapy related AML (t-AML) --> MYST3 / CREBBP
Disease Erythrophagocytosis; rare: less than 1% of AML; found in children and young adults of both sex
Prognosis poor
Hybrid/Mutated Gene 5¹ MYST3 - 3¹ CREBBP
Abnormal Protein The fusion product retains the zinc fingers, the HAT domain of MYST3 and most of CREBBP, including the CREBBP interacting domain and the HAT domain; the fusion protein may repressRUNX1-dependant gene expression£.
  
Entity t(8;22) (p11; q13) in acute myelomonocytic or monocytic leukaemia (M4 or M5 AML) --> MYST3 / EP300
Disease Erythrophagocytosis; very rare: less than 5 cases.
Prognosis likely to be poor
Oncogenesis EP300 is very similar to CRBBP (see above), the breakpoints on these 2 genes are on homologous regions; the breakpoint on MYST3 is more proximal in the t(8;22).
  

Breakpoints

 
 

To be noted

MYST3 and MLL share: a common dual transcription activation / repression activity; probable or certain HOX genes expression regulation; 2 common translocation partners: CREBBP and EP300 giving rise to AML and t-AML with poor prognoses

External links

Nomenclature
HugoMYST3
GDBMYST3
Entrez_GeneMYST3  7994  MYST histone acetyltransferase (monocytic leukemia) 3
Cards
AtlasMYST3ID25ch8p11
GeneCardsMYST3
EnsemblMYST3 [Search_View]   ENSG00000083168 [Gene_View]
GenatlasMYST3
GeneLynxMYST3
eGenomeMYST3
euGene7994
Genomic and cartography
GoldenPathMYST3  -  8p11   chr8:41906154-42028662 -  8p11   [Description]    (hg18-Mar_2006)
EnsemblMYST3 - 8p11 [CytoView]
NCBIMapview
OMIMDisease map [OMIM]
HomoloGeneMYST3
Gene and transcription
GenbankAK027361 [ ENTREZ ]
GenbankAK128323 [ ENTREZ ]
GenbankBC018011 [ ENTREZ ]
GenbankBC142659 [ ENTREZ ]
GenbankBC142959 [ ENTREZ ]
RefSeqNM_001099412 [ SRS ]    NM_001099412 [ ENTREZ ]
RefSeqNM_001099413 [ SRS ]    NM_001099413 [ ENTREZ ]
RefSeqNM_006766 [ SRS ]    NM_006766 [ ENTREZ ]
RefSeqAC_000051 [ SRS ]    AC_000051 [ ENTREZ ]
RefSeqNC_000008 [ SRS ]    NC_000008 [ ENTREZ ]
RefSeqNT_007995 [ SRS ]    NT_007995 [ ENTREZ ]
RefSeqNW_923907 [ SRS ]    NW_923907 [ ENTREZ ]
AceViewMYST3 AceView - NCBI
UnigeneHs.491577 [ SRS ]    Hs.491577 [ NCBI ]     HS491577 [ spliceNest ]
Fast-db4495 (alternative variants)
Protein : pattern, domain, 3D structure
SwissProtQ92794 [ SRS]    Q92794 [ EXPASY ]     Q92794 [ INTERPRO ]
PrositePS01359 ZF_PHD_1 [ SRS ]    PS01359 ZF_PHD_1 [ Expasy ]
PrositePS50016 ZF_PHD_2 [ SRS ]    PS50016 ZF_PHD_2 [ Expasy ]
InterproIPR005818 Histone_H1/H5 [ SRS ]    IPR005818 Histone_H1/H5 [ EBI ]
InterproIPR002717 MOZ_SAS [ SRS ]    IPR002717 MOZ_SAS [ EBI ]
InterproIPR011991 Wing_hlx_DNA_bd [ SRS ]    IPR011991 Wing_hlx_DNA_bd [ EBI ]
InterproIPR001965 Znf_PHD [ SRS ]    IPR001965 Znf_PHD [ EBI ]
InterproIPR001841 Znf_RING [ SRS ]    IPR001841 Znf_RING [ EBI ]
InterproIPR013083 Znf_RING/FYVE/PHD [ SRS ]    IPR013083 Znf_RING/FYVE/PHD [ EBI ]
CluSTrQ92794
PfamPF01853 MOZ_SAS [ SRS ]    PF01853 MOZ_SAS [ Sanger ]    pfam01853 [ NCBI-CDD ]
PfamPF00628 PHD [ SRS ]    PF00628 PHD [ Sanger ]    pfam00628 [ NCBI-CDD ]
SmartSM00526 H15 [EMBL]
SmartSM00249 PHD [EMBL]
SmartSM00184 RING [EMBL]
BlocksQ92794
PDB1M36 [ SRS ]    1M36 [ PdbSum ],   1M36 [ IMB ]   1M36 [ RSDB ]
PDB2OZU [ SRS ]    2OZU [ PdbSum ],   2OZU [ IMB ]   2OZU [ RSDB ]
HPRD03244
Protein Interaction databases
DIPQ92794
IntActQ92794
Polymorphism : SNP, mutations, diseases
OMIM601408    [ map ]   
GENECLINICS601408
SNPMYST3 [dbSNP-NCBI]  
SNPNM_001099412 [SNP-NCI]  
SNPNM_001099413 [SNP-NCI]  
SNPNM_006766 [SNP-NCI]  
SNPMYST3 [GeneSNPs - Utah]  MYST3] [HGBASE - SRS]
HAPMAPMYST3 [HAPMAP]  
COSMICMYST3 [Somatic mutation (COSMIC-CGP-Sanger)]  
HGMDMYST3
General knowledge
Family BrowserMYST3 [UCSC Family Browser]
SOURCENM_001099412
SOURCENM_001099413
SOURCENM_006766
SMDHs.491577
SAGEHs.491577
Enzyme2.3.1.48 [ Enzyme-SRS ]   2.3.1.48 [ Brenda-SRS ]   2.3.1.48 [ KEGG ]   2.3.1.48 [ WIT ]
GOnucleosome [Amigo]  nucleosome
GODNA binding [Amigo]  DNA binding
GOhistone acetyltransferase activity [Amigo]  histone acetyltransferase activity
GOnucleus [Amigo]  nucleus
GODNA packaging [Amigo]  DNA packaging
GOnucleosome assembly [Amigo]  nucleosome assembly
GOtranscription [Amigo]  transcription
GOregulation of transcription, DNA-dependent [Amigo]  regulation of transcription, DNA-dependent
GOtranscription factor binding [Amigo]  transcription factor binding
GOzinc ion binding [Amigo]  zinc ion binding
GOacetyltransferase activity [Amigo]  acetyltransferase activity
GOnegative regulation of transcription [Amigo]  negative regulation of transcription
GOchromatin modification [Amigo]  chromatin modification
GOhistone acetylation [Amigo]  histone acetylation
GOtransferase activity [Amigo]  transferase activity
GOmyeloid cell differentiation [Amigo]  myeloid cell differentiation
GOpositive regulation of transcription [Amigo]  positive regulation of transcription
GOmetal ion binding [Amigo]  metal ion binding
KEGGValine, leucine and isoleucine degradation
KEGGTyrosine metabolism
KEGGPhenylalanine metabolism
KEGGGlycerophospholipid metabolism
KEGG1- and 2-Methylnaphthalene degradation
KEGGBenzoate degradation via CoA ligation
KEGGEthylbenzene degradation
KEGGLimonene and pinene degradation
KEGGAlkaloid biosynthesis II
PubGeneMYST3
TreeFamMYST3
CTD7994 [Comparative ToxicoGenomics Database]
Other databases
Probes
ProbeMYST3 Related clones (RZPD - Berlin)
PubMed
PubMed20 Pubmed reference(s) in LocusLink

Bibliography

Three cases of translocation (8;16)(p11;p13) observed in acute myelomonocytic leukemia: a new specific subgroup?
LaˆØ JL, Zandecki M, Jouet JP, Savary JB, Lambiliotte A, Bauters F, Cosson A, Deminatti M
Cancer genetics and cytogenetics. 1987 ; 27 (1) : 101-109.
PMID 3472640
 
The 8p11 anomaly in monoblastic leukaemia.
Brizard A, Guilhot F, Huret JL, Benz-Lemoine E, Tanzer J
Leukemia research. 1988 ; 12 (8) : 693-697.
PMID 3184987
 
The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein.
Borrow J, Stanton VP Jr, Andresen JM, Becher R, Behm FG, Chaganti RS, Civin CI, Disteche C, Dubˆ© I, Frischauf AM, Horsman D, Mitelman F, Volinia S, Watmore AE, Housman DE
Nature genetics. 1996 ; 14 (1) : 33-41.
PMID 8782817
 
Abnormalities of chromosome band 8p11 in leukemia: two clinical syndromes can be distinguished on the basis of MOZ involvement.
Aguiar RC, Chase A, Coulthard S, Macdonald DH, Carapeti M, Reiter A, Sohal J, Lennard A, Goldman JM, Cross NC
Blood. 1997 ; 90 (8) : 3130-3135.
PMID 9376594
 
A novel fusion between MOZ and the nuclear receptor coactivator TIF2 in acute myeloid leukemia.
Carapeti M, Aguiar RC, Goldman JM, Cross NC
Blood. 1998 ; 91 (9) : 3127-3133.
PMID 9558366
 
Rearrangement of the MOZ gene in pediatric therapy-related myelodysplastic syndrome with a novel chromosomal translocation t(2;8)(p23;p11).
Imamura T, Kakazu N, Hibi S, Morimoto A, Fukushima Y, Ijuin I, Hada S, Kitabayashi I, Abe T, Imashuku S
Genes, chromosomes & cancer. 2003 ; 36 (4) : 413-419.
PMID 12619166
 
moz regulates Hox expression and pharyngeal segmental identity in zebrafish.
Miller CT, Maves L, Kimmel CB
Development (Cambridge, England). 2004 ; 131 (10) : 2443-2461.
PMID 15128673
 
The diverse superfamily of lysine acetyltransferases and their roles in leukemia and other diseases.
Yang XJ
Nucleic acids research. 2004 ; 32 (3) : 959-976.
PMID 14960713
 
REVIEW articlesautomatic search in PubMed
Last year publicationsautomatic search in PubMed

Search in all EBI   NCBI

Contributor(s)

Written12-2005Jean Loup Huret, Sylvie Senon

Citation

This paper should be referenced as such :
Huret JL, Senon S . MYST3 (MYST histone acetyltransferase (monocytic leukemia) 3. Atlas Genet Cytogenet Oncol Haematol. December 2005 .
URL : http://AtlasGeneticsOncology.org/Genes/MYST3ID25ch8p11.html

© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : Wed Jul 2 08:25:20 2008


Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

For comments and suggestions or contributions, please contact us

j.l.huret@chu-poitiers.fr.